Analyzing the prognostic value of DKK1 expression in human cancers based on bioinformatics
Author(s) -
Ruqiong Wei,
Raquel Alarcón,
Mar Requena,
Zhi-biao Tan,
Yuchang Gui,
Jincui Hu,
Ting-Pei Zhu,
Xiaoxiao Huang,
Yanyan Zhu,
Jianwen Xu
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-20-3263
Subject(s) - dkk1 , value (mathematics) , bioinformatics , expression (computer science) , computational biology , medicine , biology , computer science , genetics , wnt signaling pathway , gene , machine learning , programming language
Our findings showed that DKK1 is significantly expressed in various cancers and could be a biomarker for targeted therapy and a predictor for prognosis of these specific cancers. The bioinformatics analysis revealed a significant overexpression of DKK1 in HNSC, LUSC, and PAAD, with DKK1 overexpression being associated with adverse outcome in these patients, but how DKK1 expression levels relate to hematological malignancies and prognosis is still unclear. These new insights into the function of DKK1 may provide a basis for new targeted drug therapy and an avenue for further investigation into the mechanisms underlying carcinogenesis of DKK1 in different cancer types.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom